In addition to their natural immunomodulatory and anti-inflammatory activity, exosomes can provide a new method for targeted drug delivery. A robust and scalable method to enrich the vesicles with (water-soluble) molecules of interest, without altering their inherent properties, is invaluable to a bright future for therapeutic exosomes.
XomeXBio – a recently founded joint venture between ConvEyXO and our Chinese partner Somestech – is developing a unique microfluidic-chip-based solution. It allows precise and efficient loading, based on making the exosomes porous by squeezing them through the chip’s narrow channels. Its unique benefits include: